PSP Pharma
PSP Pharma, also known as PSP Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Georgia (GE). Founded in 2005, the company has established itself as a leader in the development and distribution of innovative healthcare solutions across the region, with a strong presence in Eastern Europe and Central Asia. Specialising in a diverse range of therapeutic areas, PSP Pharma offers unique products that cater to the evolving needs of healthcare professionals and patients alike. Their commitment to quality and innovation has earned them a reputable market position, marked by significant milestones in research and development. With a focus on enhancing patient outcomes, PSP Pharma continues to expand its portfolio, delivering high-quality pharmaceuticals that stand out for their efficacy and safety. The company’s dedication to excellence has solidified its status as a trusted partner in the healthcare sector.
DitchCarbon Score
How does PSP Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PSP Pharma's score of 31 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PSP Pharma's reported carbon emissions
In 2023, PSP Pharma reported total carbon emissions of approximately 8,363,480 kg CO2e, a significant reduction from about 10,362,920 kg CO2e in 2022. The emissions breakdown for 2023 includes approximately 5,371,320 kg CO2e from Scope 1 and about 2,992,160 kg CO2e from Scope 2. For 2024, preliminary data indicates an increase in total emissions to approximately 8,829,860 kg CO2e, with Scope 1 emissions rising to about 8,829,860 kg CO2e and Scope 2 emissions at approximately 5,694,420 kg CO2e. Despite these fluctuations, PSP Pharma has not publicly committed to specific reduction targets or initiatives, nor have they disclosed any science-based targets (SBTi) or climate pledges. The company continues to monitor and report its emissions, reflecting a commitment to transparency in its climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,587,780 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,775,140 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PSP Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
